Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 803 results for "eisai"

Eisai acquires manufacturing rights for API from Roche to trea...

Eisai has acquired the rights for manufacturing active pharmaceutical ingredients (API) for Japan from F Hoffman-La Roche for the insomnia treatment / anaesthesia induction agent flunitrazepam. The transfer of marketing authorisation held by ... Pharmaceutical Technology, 1 day ago

68 images for eisai

Pharma Letter, 3 days ago
International Business Times, 1 day ago
PharmaVOICE, 2 weeks ago
SleekMoney, 2 weeks ago
Mideast Time, 2 weeks ago
American Banking News, 2 weeks ago, 2 weeks ago
BioSpace, 1 month ago
Asian Scientist, 3 weeks ago
Pharma Letter, 1 month ago
International Business Times

Eisai to launch medication administration support device e-okusuri-sanx

Eisai Co., Ltd. has announced that the medication administration support device e-OKUSURI-SAN® will be launched today for sale to pharmacies, medical institutions and caregiving facilities in Japan. This device supports treatment administration ...
 Global Hospital & Healthcare Management2 days ago Eisai to Participate in Access Accelerated, Global Partnership to Address Rise of Non-Communicable Diseases  Sys-Con Media2 days ago Eisai acquires rights to manufacture API for flunitrazepam in Japan from Chugai & Roche  PharmaBiz3 days ago Arena Pharmaceuticals and Eisai Amend Marketing and Supply Agreement for BELVIQ Globally  Pharmacy Choice3 days ago

Arena, Eisai Modify Marketing & Supply Agreement for Belviq

Arena Pharmaceuticals, Inc. ARNA announced that it has amended the marketing and supply agreement with Eisai Co., Ltd. ESALY for Belviq. Eisai will gain global commercialization rights to Belviq including the territories retained by Arena under the ...
 Yahoo! Finance2 weeks ago
European Pharmaceutical Manufacturer

Eisai's Fycompa licensed for treatment of partial-onset seizures

Japanese-based Eisai has announced the licensing of Fycompa (perampanel) for adjunctive treatment of partial-onset seizures in Jordan, Saudi Arabia and the United Arab Emirates (UAE). Fycompa can be used to treat the seizures with or without ...
 Pharmaceutical Technology2 weeks ago Drug improves epilepsy for people with partial onset seizures  European Pharmaceutical Manufacturer1 month ago

Hudhud-hit ZP High School turns smart

It was a memorable occasion for the students of the Zilla Parishad High School at Yarada. Representatives of Eisai Pharmaceuticals India Private Ltd., from seven countries, visited their school on Tuesday. Yarada, a fishing village, is cut off ...
 The Hindu1 month ago

Interim Results from Phase 1b/2 Study Evaluating the Combination of Merck's KEYTRUDA® pembrolizumab and Eisai's HALAVEN® eribulin mesylate Injection...

Interim Results from Phase 1b/2 Study Evaluating the Combination of Merck's KEYTRUDA pembrolizumab and Eisai's HALAVEN eribulin mesylate Injection in Metastatic Triple-Negative Breast Cancer Presented at 2016 SABCS By a News Reporter-Staff News ...
 Pharmacy Choice4 weeks ago Combination of Merck's Keytruda and Eisai's Halaven shows positive effect in treatment-resistant breast cancer  Seeking Alpha1 month ago Merck, Eisai Announce Interim Data Investigating Keytruda, Halaven Combination  Nasdaq1 month ago BRIEF-Interim results from phase 1b/2 study evaluating the combination of Merck's Keytruda and Eisai's Halaven injection presented at 2016 SABCS (MRK)  Business Insider1 month ago

Merck (MRK) Offers Update on Keytruda-Halaven Combination

Merck & Co., Inc. MRK and partner Eisai Co., Ltd. ESALY announced new interim data from a phase Ib/II study on the Keytruda-Halaven combination for the treatment of metastatic triple-negative breast cancer (TNBC). A look at Merck year-to-date ...
 Zacks.com1 month ago

Eisai Joins Other Biopharma Companies In First Global Initiative

JERUSALEM, ISRAEL - MARCH 10: (ISRAEL OUT) Teva Pharmaceuticals workers pack drugs in a clean room at the company's manufacturing plant March 10, 2008 in Jerusalem. Teva is regarded as the world's largest generic drug maker. (Photo : Uriel Sinai/) ...
 ITechPost22 hours ago Shionogi : Participation in the global, multi-stakeholder collaboration, called Access Accelerated  4 Traders2 days ago 22 Biopharma Companies Partner and Launch First-of-its-kind Global Initiative to Address Rise of Non-Communicable Diseases  International Business Times2 days ago 22 Biopharma Companies Partner, Launch First-of-Its-kind Global Initiative to Address Rise of Non-Communicable Diseases  Pharmacy Choice20 hours ago
Mideast Time

Eisai Co., Ltd (ESALY) Stock Rating Upgraded by Zacks Investment Research

Eisai Co., Ltd (NASDAQ:ESALY) According to Zacks, Eisai Co LTD is involved in the Biotechnology and Drug Industry. Their principle activities are the manufacture and sale of pharmaceutical products. Operations are carried out through the following ...
 Mideast Time2 weeks ago Eisai Co., Ltd (ESALY) Lifted to Hold at Zacks Investment Research  SleekMoney2 weeks ago Eisai Co., Ltd (ESALY) Upgraded to Hold by Zacks Investment Research  WKRB News2 weeks ago

EISAI : First-in-class Epilepsy Treatment Fycompa(R) (perampanel) Launches in Jordan, Kingdom of Saudi Arabia and the United Arab Emirates - Press Release issued by Eisai

Following is the text of press release issued by Eisai Quote Fycompa(R) (perampanel) is now licensed for adjunctive treatment of partial-onset seizures, with or without secondarily generalised seizures in Jordan, Kingdom of Saudi Arabia and ...
 4 Traders2 weeks ago First-in-class Epilepsy Treatment Fycompa® (perampanel) Launches in Jordan, Kingdom of Saudi Arabia and the United Arab Emirates  Yahoo! Finance2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less